Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery

IMPORTANCE: Vitreoretinal surgery can be technically challenging and is limited by physiologic characteristics of the surgeon. Factors that improve accuracy and precision of the vitreoretinal surgeon are invaluable to surgical performance. OBJECTIVES: To establish weight-adjusted cutoffs for caffein...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of ophthalmology (1960) 2020-08, Vol.138 (8), p.819-825
Hauptverfasser: Roizenblatt, Marina, Dias Gomes Barrios Marin, Vitor, Grupenmacher, Alex Treiger, Muralha, Felipe, Faber, Jean, Jiramongkolchai, Kim, Gehlbach, Peter Louis, Farah, Michel Eid, Belfort, Rubens, Maia, Mauricio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 825
container_issue 8
container_start_page 819
container_title Archives of ophthalmology (1960)
container_volume 138
creator Roizenblatt, Marina
Dias Gomes Barrios Marin, Vitor
Grupenmacher, Alex Treiger
Muralha, Felipe
Faber, Jean
Jiramongkolchai, Kim
Gehlbach, Peter Louis
Farah, Michel Eid
Belfort, Rubens
Maia, Mauricio
description IMPORTANCE: Vitreoretinal surgery can be technically challenging and is limited by physiologic characteristics of the surgeon. Factors that improve accuracy and precision of the vitreoretinal surgeon are invaluable to surgical performance. OBJECTIVES: To establish weight-adjusted cutoffs for caffeine and β-blocker (propranolol) intake and to determine their interactions in association with the performance of novice vitreoretinal microsurgeons. DESIGN, SETTINGS, AND PARTICIPANTS: This single-blind cross-sectional study of 15 vitreoretinal surgeons who had less than 2 years of surgical experience was conducted from September 19, 2018, to September 25, 2019, at a dry-laboratory setting. Five simulations were performed daily for 2 days. On day 1, performance was assessed after sequential exposure to placebo, low-dose caffeine (2.5 mg/kg), high-dose caffeine (5.0 mg/kg), and high-dose propranolol (0.6 mg/kg). On day 2, performance was assessed after sequential exposure to placebo, low-dose propranolol (0.2 mg/kg), high-dose propranolol (0.6 mg/kg), and high-dose caffeine (5.0 mg/kg). INTERVENTIONS: Surgical simulation tasks were repeated 30 minutes after masked ingestion of placebo, caffeine, or propranolol pills during the 2 days. MAIN OUTCOMES AND MEASURES: An Eyesi surgical simulator was used to assess surgical performance, which included surgical score (range, 0 [worst] to 700 [best]), task completion time, intraocular trajectory, and tremor rate (range, 0 [worst] to 100 [best]). The nonparametric Friedman test followed by Dunn-Bonferroni post hoc test was applied for multiple comparisons. RESULTS: Of 15 vitreoretinal surgeons, 9 (60%) were male, with a mean (SD) age of 29.6 (1.4) years and mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) of 23.15 (2.9). Compared with low-dose propranolol, low-dose caffeine was associated with a worse total surgical score (557.0 vs 617.0; difference, –53.0; 95% CI, –99.3 to –6.7; P = .009), a lower antitremor maneuver score (55.0 vs 75.0; difference, –12.0; 95% CI, –21.2 to –2.8; P = .009), longer intraocular trajectory (2298.6 vs 2080.7 mm; difference, 179.3 mm; 95% CI, 1.2-357.3 mm; P = .048), and increased task completion time (14.9 minutes vs 12.7 minutes; difference, 2.3 minutes; 95% CI, 0.8-3.8 minutes; P = .048). Postcaffeine treatment with propranolol was associated with performance improvement; however, surgical performance remained inferior compared with low-dose pr
doi_str_mv 10.1001/jamaophthalmol.2020.1971
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7290718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>2766387</ama_id><sourcerecordid>2435850580</sourcerecordid><originalsourceid>FETCH-LOGICAL-a397t-d0022e8f19b0accd0aa57b11a9ff0cb646754345dbd7697d7bf411637cabd5a43</originalsourceid><addsrcrecordid>eNpVkd1u1DAQhSMEolXpC3CBLHGd4p84Tm6QloUCUlGRoPTSmsR24iWJt7YD2nfgaXgQnglHWyLqG1s6Z76Z8ckyRPAFwZi82sEIbt_HHobRDRcU0yTUgjzKTikpq7wkgj1e3yU_yc5D2OF0KowLxp9mJ4xyyjkRp9mvTQiutRCtm5Az6Fbbro_5Ru3mELVCWzBG20kjmBT68zt_M7j2u_boJmh0a2OPrtdJXHdAl3oY3E_0WXvj_AhTq9Hb2dupQ1_sOA-wIL_Z6LXzOtoJBvTJtt6F2XfaH55lTwwMQZ_f32fZzeW7r9sP-dX1-4_bzVUOrBYxVxhTqitD6gZD2yoMwEVDCNTG4LYpi1LwghVcNUqUtVCiMQUhJRMtNIpDwc6y10fufm5GrVo9RQ-D3Hs7gj9IB1Y-VCbby879kILWWJAqAV7eA7y7m3WIcudmn9YJkqYfrjjmFU6u6uhaNgxem7UDwXKJUj6MUi5RyiXKVPri_wnXwn_BJcPzoyERVpWKsmSVYH8BoUWsZw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2435850580</pqid></control><display><type>article</type><title>Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery</title><source>MEDLINE</source><source>American Medical Association Journals</source><source>Alma/SFX Local Collection</source><creator>Roizenblatt, Marina ; Dias Gomes Barrios Marin, Vitor ; Grupenmacher, Alex Treiger ; Muralha, Felipe ; Faber, Jean ; Jiramongkolchai, Kim ; Gehlbach, Peter Louis ; Farah, Michel Eid ; Belfort, Rubens ; Maia, Mauricio</creator><creatorcontrib>Roizenblatt, Marina ; Dias Gomes Barrios Marin, Vitor ; Grupenmacher, Alex Treiger ; Muralha, Felipe ; Faber, Jean ; Jiramongkolchai, Kim ; Gehlbach, Peter Louis ; Farah, Michel Eid ; Belfort, Rubens ; Maia, Mauricio</creatorcontrib><description>IMPORTANCE: Vitreoretinal surgery can be technically challenging and is limited by physiologic characteristics of the surgeon. Factors that improve accuracy and precision of the vitreoretinal surgeon are invaluable to surgical performance. OBJECTIVES: To establish weight-adjusted cutoffs for caffeine and β-blocker (propranolol) intake and to determine their interactions in association with the performance of novice vitreoretinal microsurgeons. DESIGN, SETTINGS, AND PARTICIPANTS: This single-blind cross-sectional study of 15 vitreoretinal surgeons who had less than 2 years of surgical experience was conducted from September 19, 2018, to September 25, 2019, at a dry-laboratory setting. Five simulations were performed daily for 2 days. On day 1, performance was assessed after sequential exposure to placebo, low-dose caffeine (2.5 mg/kg), high-dose caffeine (5.0 mg/kg), and high-dose propranolol (0.6 mg/kg). On day 2, performance was assessed after sequential exposure to placebo, low-dose propranolol (0.2 mg/kg), high-dose propranolol (0.6 mg/kg), and high-dose caffeine (5.0 mg/kg). INTERVENTIONS: Surgical simulation tasks were repeated 30 minutes after masked ingestion of placebo, caffeine, or propranolol pills during the 2 days. MAIN OUTCOMES AND MEASURES: An Eyesi surgical simulator was used to assess surgical performance, which included surgical score (range, 0 [worst] to 700 [best]), task completion time, intraocular trajectory, and tremor rate (range, 0 [worst] to 100 [best]). The nonparametric Friedman test followed by Dunn-Bonferroni post hoc test was applied for multiple comparisons. RESULTS: Of 15 vitreoretinal surgeons, 9 (60%) were male, with a mean (SD) age of 29.6 (1.4) years and mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) of 23.15 (2.9). Compared with low-dose propranolol, low-dose caffeine was associated with a worse total surgical score (557.0 vs 617.0; difference, –53.0; 95% CI, –99.3 to –6.7; P = .009), a lower antitremor maneuver score (55.0 vs 75.0; difference, –12.0; 95% CI, –21.2 to –2.8; P = .009), longer intraocular trajectory (2298.6 vs 2080.7 mm; difference, 179.3 mm; 95% CI, 1.2-357.3 mm; P = .048), and increased task completion time (14.9 minutes vs 12.7 minutes; difference, 2.3 minutes; 95% CI, 0.8-3.8 minutes; P = .048). Postcaffeine treatment with propranolol was associated with performance improvement; however, surgical performance remained inferior compared with low-dose propranolol alone for total surgical score (570.0 vs 617.0; difference, –51.0; 95% CI, –77.6 to –24.4; P = .01), tremor-specific score (50.0 vs 75.0; difference, –16.0; 95% CI, –31.8 to –0.2; P = .03), and intraocular trajectory (2265.9 mm vs 2080.7 mm; difference, 166.8 mm; 95% CI, 64.1-269.6 mm; P = .03). CONCLUSIONS AND RELEVANCE: The findings suggest that performance of novice vitreoretinal surgeons was worse after receiving low-dose caffeine alone but improved after receiving low-dose propranolol alone. Their performance after receiving propranolol alone was better than after the combination of propranolol and caffeine. These results may be helpful for novice vitreoretinal surgeons to improve microsurgical performance.</description><identifier>ISSN: 2168-6165</identifier><identifier>EISSN: 2168-6173</identifier><identifier>DOI: 10.1001/jamaophthalmol.2020.1971</identifier><identifier>PMID: 32525517</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adrenergic beta-Antagonists - administration &amp; dosage ; Adult ; Beta blockers ; Body Mass Index ; Caffeine ; Caffeine - administration &amp; dosage ; Central Nervous System Stimulants - administration &amp; dosage ; Clinical Competence ; Comments ; Computer Simulation ; Cross-Sectional Studies ; Drug Combinations ; Fellowships and Scholarships ; Female ; Humans ; Male ; Microsurgery ; Online First ; Ophthalmology - education ; Original Investigation ; Propranolol ; Propranolol - administration &amp; dosage ; Psychomotor Performance - drug effects ; Single-Blind Method ; Surgeons ; Surgery ; Tremor ; Vitreoretinal Surgery</subject><ispartof>Archives of ophthalmology (1960), 2020-08, Vol.138 (8), p.819-825</ispartof><rights>Copyright American Medical Association Aug 2020</rights><rights>Copyright 2020 American Medical Association. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a397t-d0022e8f19b0accd0aa57b11a9ff0cb646754345dbd7697d7bf411637cabd5a43</citedby><cites>FETCH-LOGICAL-a397t-d0022e8f19b0accd0aa57b11a9ff0cb646754345dbd7697d7bf411637cabd5a43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jamaophthalmology/articlepdf/10.1001/jamaophthalmol.2020.1971$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2020.1971$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,230,314,780,784,885,3338,27923,27924,76260,76263</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32525517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roizenblatt, Marina</creatorcontrib><creatorcontrib>Dias Gomes Barrios Marin, Vitor</creatorcontrib><creatorcontrib>Grupenmacher, Alex Treiger</creatorcontrib><creatorcontrib>Muralha, Felipe</creatorcontrib><creatorcontrib>Faber, Jean</creatorcontrib><creatorcontrib>Jiramongkolchai, Kim</creatorcontrib><creatorcontrib>Gehlbach, Peter Louis</creatorcontrib><creatorcontrib>Farah, Michel Eid</creatorcontrib><creatorcontrib>Belfort, Rubens</creatorcontrib><creatorcontrib>Maia, Mauricio</creatorcontrib><title>Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery</title><title>Archives of ophthalmology (1960)</title><addtitle>JAMA Ophthalmol</addtitle><description>IMPORTANCE: Vitreoretinal surgery can be technically challenging and is limited by physiologic characteristics of the surgeon. Factors that improve accuracy and precision of the vitreoretinal surgeon are invaluable to surgical performance. OBJECTIVES: To establish weight-adjusted cutoffs for caffeine and β-blocker (propranolol) intake and to determine their interactions in association with the performance of novice vitreoretinal microsurgeons. DESIGN, SETTINGS, AND PARTICIPANTS: This single-blind cross-sectional study of 15 vitreoretinal surgeons who had less than 2 years of surgical experience was conducted from September 19, 2018, to September 25, 2019, at a dry-laboratory setting. Five simulations were performed daily for 2 days. On day 1, performance was assessed after sequential exposure to placebo, low-dose caffeine (2.5 mg/kg), high-dose caffeine (5.0 mg/kg), and high-dose propranolol (0.6 mg/kg). On day 2, performance was assessed after sequential exposure to placebo, low-dose propranolol (0.2 mg/kg), high-dose propranolol (0.6 mg/kg), and high-dose caffeine (5.0 mg/kg). INTERVENTIONS: Surgical simulation tasks were repeated 30 minutes after masked ingestion of placebo, caffeine, or propranolol pills during the 2 days. MAIN OUTCOMES AND MEASURES: An Eyesi surgical simulator was used to assess surgical performance, which included surgical score (range, 0 [worst] to 700 [best]), task completion time, intraocular trajectory, and tremor rate (range, 0 [worst] to 100 [best]). The nonparametric Friedman test followed by Dunn-Bonferroni post hoc test was applied for multiple comparisons. RESULTS: Of 15 vitreoretinal surgeons, 9 (60%) were male, with a mean (SD) age of 29.6 (1.4) years and mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) of 23.15 (2.9). Compared with low-dose propranolol, low-dose caffeine was associated with a worse total surgical score (557.0 vs 617.0; difference, –53.0; 95% CI, –99.3 to –6.7; P = .009), a lower antitremor maneuver score (55.0 vs 75.0; difference, –12.0; 95% CI, –21.2 to –2.8; P = .009), longer intraocular trajectory (2298.6 vs 2080.7 mm; difference, 179.3 mm; 95% CI, 1.2-357.3 mm; P = .048), and increased task completion time (14.9 minutes vs 12.7 minutes; difference, 2.3 minutes; 95% CI, 0.8-3.8 minutes; P = .048). Postcaffeine treatment with propranolol was associated with performance improvement; however, surgical performance remained inferior compared with low-dose propranolol alone for total surgical score (570.0 vs 617.0; difference, –51.0; 95% CI, –77.6 to –24.4; P = .01), tremor-specific score (50.0 vs 75.0; difference, –16.0; 95% CI, –31.8 to –0.2; P = .03), and intraocular trajectory (2265.9 mm vs 2080.7 mm; difference, 166.8 mm; 95% CI, 64.1-269.6 mm; P = .03). CONCLUSIONS AND RELEVANCE: The findings suggest that performance of novice vitreoretinal surgeons was worse after receiving low-dose caffeine alone but improved after receiving low-dose propranolol alone. Their performance after receiving propranolol alone was better than after the combination of propranolol and caffeine. These results may be helpful for novice vitreoretinal surgeons to improve microsurgical performance.</description><subject>Adrenergic beta-Antagonists - administration &amp; dosage</subject><subject>Adult</subject><subject>Beta blockers</subject><subject>Body Mass Index</subject><subject>Caffeine</subject><subject>Caffeine - administration &amp; dosage</subject><subject>Central Nervous System Stimulants - administration &amp; dosage</subject><subject>Clinical Competence</subject><subject>Comments</subject><subject>Computer Simulation</subject><subject>Cross-Sectional Studies</subject><subject>Drug Combinations</subject><subject>Fellowships and Scholarships</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Microsurgery</subject><subject>Online First</subject><subject>Ophthalmology - education</subject><subject>Original Investigation</subject><subject>Propranolol</subject><subject>Propranolol - administration &amp; dosage</subject><subject>Psychomotor Performance - drug effects</subject><subject>Single-Blind Method</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Tremor</subject><subject>Vitreoretinal Surgery</subject><issn>2168-6165</issn><issn>2168-6173</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkd1u1DAQhSMEolXpC3CBLHGd4p84Tm6QloUCUlGRoPTSmsR24iWJt7YD2nfgaXgQnglHWyLqG1s6Z76Z8ckyRPAFwZi82sEIbt_HHobRDRcU0yTUgjzKTikpq7wkgj1e3yU_yc5D2OF0KowLxp9mJ4xyyjkRp9mvTQiutRCtm5Az6Fbbro_5Ru3mELVCWzBG20kjmBT68zt_M7j2u_boJmh0a2OPrtdJXHdAl3oY3E_0WXvj_AhTq9Hb2dupQ1_sOA-wIL_Z6LXzOtoJBvTJtt6F2XfaH55lTwwMQZ_f32fZzeW7r9sP-dX1-4_bzVUOrBYxVxhTqitD6gZD2yoMwEVDCNTG4LYpi1LwghVcNUqUtVCiMQUhJRMtNIpDwc6y10fufm5GrVo9RQ-D3Hs7gj9IB1Y-VCbby879kILWWJAqAV7eA7y7m3WIcudmn9YJkqYfrjjmFU6u6uhaNgxem7UDwXKJUj6MUi5RyiXKVPri_wnXwn_BJcPzoyERVpWKsmSVYH8BoUWsZw</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Roizenblatt, Marina</creator><creator>Dias Gomes Barrios Marin, Vitor</creator><creator>Grupenmacher, Alex Treiger</creator><creator>Muralha, Felipe</creator><creator>Faber, Jean</creator><creator>Jiramongkolchai, Kim</creator><creator>Gehlbach, Peter Louis</creator><creator>Farah, Michel Eid</creator><creator>Belfort, Rubens</creator><creator>Maia, Mauricio</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>20200801</creationdate><title>Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery</title><author>Roizenblatt, Marina ; Dias Gomes Barrios Marin, Vitor ; Grupenmacher, Alex Treiger ; Muralha, Felipe ; Faber, Jean ; Jiramongkolchai, Kim ; Gehlbach, Peter Louis ; Farah, Michel Eid ; Belfort, Rubens ; Maia, Mauricio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a397t-d0022e8f19b0accd0aa57b11a9ff0cb646754345dbd7697d7bf411637cabd5a43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adrenergic beta-Antagonists - administration &amp; dosage</topic><topic>Adult</topic><topic>Beta blockers</topic><topic>Body Mass Index</topic><topic>Caffeine</topic><topic>Caffeine - administration &amp; dosage</topic><topic>Central Nervous System Stimulants - administration &amp; dosage</topic><topic>Clinical Competence</topic><topic>Comments</topic><topic>Computer Simulation</topic><topic>Cross-Sectional Studies</topic><topic>Drug Combinations</topic><topic>Fellowships and Scholarships</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Microsurgery</topic><topic>Online First</topic><topic>Ophthalmology - education</topic><topic>Original Investigation</topic><topic>Propranolol</topic><topic>Propranolol - administration &amp; dosage</topic><topic>Psychomotor Performance - drug effects</topic><topic>Single-Blind Method</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Tremor</topic><topic>Vitreoretinal Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roizenblatt, Marina</creatorcontrib><creatorcontrib>Dias Gomes Barrios Marin, Vitor</creatorcontrib><creatorcontrib>Grupenmacher, Alex Treiger</creatorcontrib><creatorcontrib>Muralha, Felipe</creatorcontrib><creatorcontrib>Faber, Jean</creatorcontrib><creatorcontrib>Jiramongkolchai, Kim</creatorcontrib><creatorcontrib>Gehlbach, Peter Louis</creatorcontrib><creatorcontrib>Farah, Michel Eid</creatorcontrib><creatorcontrib>Belfort, Rubens</creatorcontrib><creatorcontrib>Maia, Mauricio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of ophthalmology (1960)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roizenblatt, Marina</au><au>Dias Gomes Barrios Marin, Vitor</au><au>Grupenmacher, Alex Treiger</au><au>Muralha, Felipe</au><au>Faber, Jean</au><au>Jiramongkolchai, Kim</au><au>Gehlbach, Peter Louis</au><au>Farah, Michel Eid</au><au>Belfort, Rubens</au><au>Maia, Mauricio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery</atitle><jtitle>Archives of ophthalmology (1960)</jtitle><addtitle>JAMA Ophthalmol</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>138</volume><issue>8</issue><spage>819</spage><epage>825</epage><pages>819-825</pages><issn>2168-6165</issn><eissn>2168-6173</eissn><abstract>IMPORTANCE: Vitreoretinal surgery can be technically challenging and is limited by physiologic characteristics of the surgeon. Factors that improve accuracy and precision of the vitreoretinal surgeon are invaluable to surgical performance. OBJECTIVES: To establish weight-adjusted cutoffs for caffeine and β-blocker (propranolol) intake and to determine their interactions in association with the performance of novice vitreoretinal microsurgeons. DESIGN, SETTINGS, AND PARTICIPANTS: This single-blind cross-sectional study of 15 vitreoretinal surgeons who had less than 2 years of surgical experience was conducted from September 19, 2018, to September 25, 2019, at a dry-laboratory setting. Five simulations were performed daily for 2 days. On day 1, performance was assessed after sequential exposure to placebo, low-dose caffeine (2.5 mg/kg), high-dose caffeine (5.0 mg/kg), and high-dose propranolol (0.6 mg/kg). On day 2, performance was assessed after sequential exposure to placebo, low-dose propranolol (0.2 mg/kg), high-dose propranolol (0.6 mg/kg), and high-dose caffeine (5.0 mg/kg). INTERVENTIONS: Surgical simulation tasks were repeated 30 minutes after masked ingestion of placebo, caffeine, or propranolol pills during the 2 days. MAIN OUTCOMES AND MEASURES: An Eyesi surgical simulator was used to assess surgical performance, which included surgical score (range, 0 [worst] to 700 [best]), task completion time, intraocular trajectory, and tremor rate (range, 0 [worst] to 100 [best]). The nonparametric Friedman test followed by Dunn-Bonferroni post hoc test was applied for multiple comparisons. RESULTS: Of 15 vitreoretinal surgeons, 9 (60%) were male, with a mean (SD) age of 29.6 (1.4) years and mean (SD) body mass index (calculated as weight in kilograms divided by height in meters squared) of 23.15 (2.9). Compared with low-dose propranolol, low-dose caffeine was associated with a worse total surgical score (557.0 vs 617.0; difference, –53.0; 95% CI, –99.3 to –6.7; P = .009), a lower antitremor maneuver score (55.0 vs 75.0; difference, –12.0; 95% CI, –21.2 to –2.8; P = .009), longer intraocular trajectory (2298.6 vs 2080.7 mm; difference, 179.3 mm; 95% CI, 1.2-357.3 mm; P = .048), and increased task completion time (14.9 minutes vs 12.7 minutes; difference, 2.3 minutes; 95% CI, 0.8-3.8 minutes; P = .048). Postcaffeine treatment with propranolol was associated with performance improvement; however, surgical performance remained inferior compared with low-dose propranolol alone for total surgical score (570.0 vs 617.0; difference, –51.0; 95% CI, –77.6 to –24.4; P = .01), tremor-specific score (50.0 vs 75.0; difference, –16.0; 95% CI, –31.8 to –0.2; P = .03), and intraocular trajectory (2265.9 mm vs 2080.7 mm; difference, 166.8 mm; 95% CI, 64.1-269.6 mm; P = .03). CONCLUSIONS AND RELEVANCE: The findings suggest that performance of novice vitreoretinal surgeons was worse after receiving low-dose caffeine alone but improved after receiving low-dose propranolol alone. Their performance after receiving propranolol alone was better than after the combination of propranolol and caffeine. These results may be helpful for novice vitreoretinal surgeons to improve microsurgical performance.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>32525517</pmid><doi>10.1001/jamaophthalmol.2020.1971</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2168-6165
ispartof Archives of ophthalmology (1960), 2020-08, Vol.138 (8), p.819-825
issn 2168-6165
2168-6173
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7290718
source MEDLINE; American Medical Association Journals; Alma/SFX Local Collection
subjects Adrenergic beta-Antagonists - administration & dosage
Adult
Beta blockers
Body Mass Index
Caffeine
Caffeine - administration & dosage
Central Nervous System Stimulants - administration & dosage
Clinical Competence
Comments
Computer Simulation
Cross-Sectional Studies
Drug Combinations
Fellowships and Scholarships
Female
Humans
Male
Microsurgery
Online First
Ophthalmology - education
Original Investigation
Propranolol
Propranolol - administration & dosage
Psychomotor Performance - drug effects
Single-Blind Method
Surgeons
Surgery
Tremor
Vitreoretinal Surgery
title Association of Weight-Adjusted Caffeine and β-Blocker Use With Ophthalmology Fellow Performance During Simulated Vitreoretinal Microsurgery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A10%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20Weight-Adjusted%20Caffeine%20and%20%CE%B2-Blocker%20Use%20With%20Ophthalmology%20Fellow%20Performance%20During%20Simulated%20Vitreoretinal%20Microsurgery&rft.jtitle=Archives%20of%20ophthalmology%20(1960)&rft.au=Roizenblatt,%20Marina&rft.date=2020-08-01&rft.volume=138&rft.issue=8&rft.spage=819&rft.epage=825&rft.pages=819-825&rft.issn=2168-6165&rft.eissn=2168-6173&rft_id=info:doi/10.1001/jamaophthalmol.2020.1971&rft_dat=%3Cproquest_pubme%3E2435850580%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2435850580&rft_id=info:pmid/32525517&rft_ama_id=2766387&rfr_iscdi=true